Twist Bioscience
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $96,057 | $92,793 | $88,713 | $84,710 |
Gross Profit | 51,297 | 46,028 | 42,840 | 38,233 |
EBITDA | -24,055 | -46,266 | -25,093 | -28,067 |
EBIT | -30,120 | -39,886 | -31,473 | -34,723 |
Net Income | 20,390 | -39,328 | -31,594 | -34,655 |
Net Change In Cash | 96,057 | 92,793 | 88,713 | 84,710 |
Free Cash Flow | -10,565 | -17,130 | -23,696 | -17,322 |
Cash | 201,373 | 210,437 | 221,403 | 226,316 |
Basic Shares | 61,164 | 59,649 | 59,162 | 58,016 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $312,974 | $245,109 | $203,565 | $132,333 |
Gross Profit | 133,349 | 89,729 | 84,235 | 51,713 |
EBITDA | -176,705 | -174,151 | -247,046 | -143,911 |
EBIT | -208,137 | -203,461 | -249,021 | -155,904 |
Net Income | -208,726 | -204,618 | -217,863 | -152,098 |
Net Change In Cash | 312,974 | 245,109 | 203,565 | 132,333 |
Cost of Revenue | -86,781 | 373,093 | ||
Free Cash Flow | -69,170 | -170,253 | -226,242 | -139,305 |
Cash | 226,316 | 286,470 | 378,687 | 465,829 |
Basic Shares | 58,016 | 56,885 | 53,885 | 48,251 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.47 |
2025-03-31 | -$0.66 |
2024-12-31 | -$0.53 |
